News
1d
HealthDay on MSNENDO: Superior Weight Loss Seen With Tirzepatide and Menopausal Hormone Therapy UseIn postmenopausal women with overweight or obesity receiving tirzepatide, use of menopausal hormone therapy (MHT) is ...
Mallinckrodt plc today announced that the Irish High Court has given the necessary ruling to enable its combination with Endo, Inc. (OTCQX: NDOI), advancing the companies' plan to merge in a stock and ...
2d
InvestorsHub on MSNRani Therapeutics Shares Surge After ENDO 2025 Presentation AnnouncementRani Therapeutics Holdings Inc (NASDAQ:RANI) experienced an 18% jump in its stock price following news that the ...
Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label ...
T is a Novel, Non-Aromatizing Androgen, Offering the Benefits of Testosterone Without Converting to Estradiol Addressing a ...
(HealthDay News) — From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July ...
Sweetener consumption and genetic predisposition are independently associated with the risk for central precocious puberty (CPP), according to a study presented at ENDO 2025, the annual meeting of the ...
ENDO 2025 Obesity-Related Cancer Deaths More Than Triple Rural, older, Black, and female Americans bear the brunt of the surge in obesity-related cancer mortality, new data show. News, July 15 ...
ENDO 2025 spotlights breakthrough research in PCOS, obesity, diabetes, and rare endocrine disorders and offers practical updates for daily clinical care. As the sun rises over San Francisco, ...
Socially Isolated Older Adults are at 34% Higher Risk of Diabetes: ENDO 2025 StudyA study presented at ENDO 2025, the Endocrine Society’s annual meeting ...
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics ...
SOUTH SAN FRANCISCO, CA, USA I July 14, 2025 I Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results